
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Sugar-Coated Killer: Serotype 3 Pneumococcal Disease
Jennifer N. Luck, Hervé Tettelin, Carlos J. Orihuela
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 84
Jennifer N. Luck, Hervé Tettelin, Carlos J. Orihuela
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 84
Showing 1-25 of 84 citing articles:
Bacterial capsules: Occurrence, mechanism, and function
Shuji Gao, Wenjie Jin, Yingying Quan, et al.
npj Biofilms and Microbiomes (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 21
Shuji Gao, Wenjie Jin, Yingying Quan, et al.
npj Biofilms and Microbiomes (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 21
Distribution of Serotypes Causing Invasive Pneumococcal Disease in Children From High-Income Countries and the Impact of Pediatric Pneumococcal Vaccination
Lindsay R. Grant, Mary Slack, Christian Theilacker, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e1062-e1070
Open Access | Times Cited: 53
Lindsay R. Grant, Mary Slack, Christian Theilacker, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e1062-e1070
Open Access | Times Cited: 53
Emerging vaccine strategies against the incessant pneumococcal disease
Jeremy A. Duke, Fikri Y. Avci
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 26
Jeremy A. Duke, Fikri Y. Avci
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 26
Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease among children in the United States between 2010 and 2019: An indirect cohort study
Kristin L. Andrejko, Ryan Gierke, Jemma V. Rowlands, et al.
Vaccine (2024) Vol. 42, Iss. 16, pp. 3555-3563
Open Access | Times Cited: 13
Kristin L. Andrejko, Ryan Gierke, Jemma V. Rowlands, et al.
Vaccine (2024) Vol. 42, Iss. 16, pp. 3555-3563
Open Access | Times Cited: 13
Streptococcus pneumoniae epidemiology, pathogenesis and control
Ana Rita Narciso, Rebecca S. Dookie, Priyanka Nannapaneni, et al.
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 10
Ana Rita Narciso, Rebecca S. Dookie, Priyanka Nannapaneni, et al.
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 10
Clonal Expansion of a Streptococcus pneumoniae Serotype 3 Capsule Variant Sequence Type 700 With Enhanced Vaccine Escape Potential After 13-Valent Pneumococcal Conjugate Vaccine Introduction
Akuzike Kalizang’oma, Todd D. Swarthout, Thandie S. Mwalukomo, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 1, pp. e189-e198
Open Access | Times Cited: 6
Akuzike Kalizang’oma, Todd D. Swarthout, Thandie S. Mwalukomo, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 1, pp. e189-e198
Open Access | Times Cited: 6
Evolution of invasive pneumococcal disease by serotype 3 in adults: a Spanish three-decade retrospective study
Sara Calvo-Silveria, Aida González-Díaz, Inmaculada Grau, et al.
The Lancet Regional Health - Europe (2024) Vol. 41, pp. 100913-100913
Open Access | Times Cited: 6
Sara Calvo-Silveria, Aida González-Díaz, Inmaculada Grau, et al.
The Lancet Regional Health - Europe (2024) Vol. 41, pp. 100913-100913
Open Access | Times Cited: 6
A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom
James Campling, Andrew Vyse, Hui-Hsuan Liu, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 785-800
Open Access | Times Cited: 16
James Campling, Andrew Vyse, Hui-Hsuan Liu, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 785-800
Open Access | Times Cited: 16
A narrative review of genomic characteristics, serotype, immunogenicity, and vaccine development of Streptococcus pneumoniae capsular polysaccharide
Ratna Fathma Sari, Fadilah Fadilah, Yustinus Maladan, et al.
Clinical and Experimental Vaccine Research (2024) Vol. 13, Iss. 2, pp. 91-91
Open Access | Times Cited: 5
Ratna Fathma Sari, Fadilah Fadilah, Yustinus Maladan, et al.
Clinical and Experimental Vaccine Research (2024) Vol. 13, Iss. 2, pp. 91-91
Open Access | Times Cited: 5
Capsule Promotes Intracellular Survival and Vascular Endothelial Cell Translocation during Invasive Pneumococcal Disease
Terry Brissac, Eriel Martínez, Katherine L. Kruckow, et al.
mBio (2021) Vol. 12, Iss. 5
Open Access | Times Cited: 30
Terry Brissac, Eriel Martínez, Katherine L. Kruckow, et al.
mBio (2021) Vol. 12, Iss. 5
Open Access | Times Cited: 30
Multi-Valent Protein Hybrid Pneumococcal Vaccines: A Strategy for the Next Generation of Vaccines
Ninecia R. Scott, Beth Mann, Elaine Tuomanen, et al.
Vaccines (2021) Vol. 9, Iss. 3, pp. 209-209
Open Access | Times Cited: 27
Ninecia R. Scott, Beth Mann, Elaine Tuomanen, et al.
Vaccines (2021) Vol. 9, Iss. 3, pp. 209-209
Open Access | Times Cited: 27
Diverse Mechanisms of Protective Anti-Pneumococcal Antibodies
Aaron D. Gingerich, Jarrod J. Mousa
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 22
Aaron D. Gingerich, Jarrod J. Mousa
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 22
20-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults
Matt Shirley
Drugs (2022) Vol. 82, Iss. 9, pp. 989-999
Open Access | Times Cited: 22
Matt Shirley
Drugs (2022) Vol. 82, Iss. 9, pp. 989-999
Open Access | Times Cited: 22
Impact of the 10-valent pneumococcal conjugate vaccine (PCV10) on pneumococcal carriage in healthy children and children with acute otitis media and pneumonia: emergence of serotypes 3, 6C and 19A in Croatia
Nina Krajcar, Vladimir Trkulja, Iva Butić, et al.
Vaccine (2025) Vol. 50, pp. 126848-126848
Open Access
Nina Krajcar, Vladimir Trkulja, Iva Butić, et al.
Vaccine (2025) Vol. 50, pp. 126848-126848
Open Access
Community acquired pneumonia due to antibiotic resistant-Streptococcus pneumoniae: diagnosis, management and prevention
Grace Lui, Christopher K.C. Lai
Current Opinion in Pulmonary Medicine (2025)
Closed Access
Grace Lui, Christopher K.C. Lai
Current Opinion in Pulmonary Medicine (2025)
Closed Access
An Insight of Streptococcus pneumoniae Serotype 3 Genomic Profile in Indonesia
Ratna Fathma Sari, Fadilah Fadilah, Yustinus Maladan, et al.
Journal of Microbiology Immunology and Infection (2025)
Open Access
Ratna Fathma Sari, Fadilah Fadilah, Yustinus Maladan, et al.
Journal of Microbiology Immunology and Infection (2025)
Open Access
Pneumokokkensepsis 2015–2022: Überlegungen zu Impfstrategien
Herbert Hof, Susanne Singer, Ika Steiner, et al.
DMW - Deutsche Medizinische Wochenschrift (2025)
Open Access
Herbert Hof, Susanne Singer, Ika Steiner, et al.
DMW - Deutsche Medizinische Wochenschrift (2025)
Open Access
Surveillance of Pediatric Invasive Bacterial Diseases in the Veneto Region: Epidemiological Trends and Outcomes over 17 Years (2007–2023)
Silvia Cocchio, Claudia Cozzolino, Andrea Cozza, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 230-230
Open Access
Silvia Cocchio, Claudia Cozzolino, Andrea Cozza, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 230-230
Open Access
Critical Quality Attributes and Manufacturing Techniques for Streptococcus pneumoniae Capsular Polysaccharide in Pneumococcal Vaccines: A Review
Yuelong Li, Xueting Huang, Qian Jin, et al.
Carbohydrate Polymer Technologies and Applications (2025), pp. 100733-100733
Open Access
Yuelong Li, Xueting Huang, Qian Jin, et al.
Carbohydrate Polymer Technologies and Applications (2025), pp. 100733-100733
Open Access
Global distribution and characteristics of pneumococcal serotypes in adults
Haruka Maeda, Konosuke Morimoto
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Haruka Maeda, Konosuke Morimoto
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Within-host pneumococcal serotype 3 genetic diversity and evolution during a one-year prolonged carriage episode in a healthy adult
Lusako Sibale, Stephanie W. Lo, Newton Kalata, et al.
Research Square (Research Square) (2025)
Closed Access
Lusako Sibale, Stephanie W. Lo, Newton Kalata, et al.
Research Square (Research Square) (2025)
Closed Access
Virulence arresting drugs discovery by strategies targeting bacterial virulence: mainly focusing on quorum-sensing interference and biofilm inhibition
Lan Lu, Tianyang Yu, Hongping Wang, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101310-101310
Open Access
Lan Lu, Tianyang Yu, Hongping Wang, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101310-101310
Open Access
Indirect Comparison of PCV20 Immunogenicity with PCV10 in Pediatric 3 + 1 and 2 + 1 Schedules
Eileen M. Dunne, Valda A. Struwig, William L. Lowe, et al.
Infectious Diseases and Therapy (2025)
Open Access
Eileen M. Dunne, Valda A. Struwig, William L. Lowe, et al.
Infectious Diseases and Therapy (2025)
Open Access
Impact of Universal PCV10 Vaccination on Invasive Pneumococcal Disease in Croatian Children
Iva Butić, Goran Tešović, Kristian Bodulić, et al.
The Pediatric Infectious Disease Journal (2025)
Closed Access
Iva Butić, Goran Tešović, Kristian Bodulić, et al.
The Pediatric Infectious Disease Journal (2025)
Closed Access
Effect of the 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in rural Gambia 10 years after its introduction: A population-based cross-sectional study
Isaac Osei, Emmanuel Mendy, Kevin van Zandvoort, et al.
Vaccine (2025) Vol. 56, pp. 127181-127181
Open Access
Isaac Osei, Emmanuel Mendy, Kevin van Zandvoort, et al.
Vaccine (2025) Vol. 56, pp. 127181-127181
Open Access